I. - Basic information

I.1 - Surname

Tisoňová

I.2 - Name

Jana

I.3 - Degrees

doc. MUDr., PhD.

I.4 - Year of birth

1969

I.5 - Name of the workplace

Medical Faculty Comenius University

I.6 - Address of the workplace

Sasinkova 4, 813 72 Bratislava

I.7 - Position

senior lecturer

I.8 - E-mail address

jana.tisonova@fmed.uniba.sk

I.9 - Hyperlink to the entry of a person in the Register of university staff

https://www.portalvs.sk/regzam/detail/3425

I.10 - Name of the study field in which a person works at the university

senior lecturer

I.11 - ORCID iD

https://orcid.org/0000-0002-5371-3640

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.a - Name of the university or institution

Medical Faculty Comenius University

II.b - Year

1993

II.c - Study field and programme

General Medicine

II.3 - Third degree of higher education

II.a - Name of the university or institution

Universitas Tyrnaviensis in Trnava

II.b - Year

2001

II.c - Study field and programme

Public Health

II.4 - Associate professor

II.a - Name of the university or institution

Faculty if Medicine Comenius University Bratislava

II.b - Year

2025

II.c - Study field and programme

Clinical pharmacology

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position	III.b - Institution	III.c - Duration
Study stay	Department of Pharmacology Comenius University	1993-1994
physician	Institute of Preventive and Clinical Science	1994 - 2000
senior lecturer	Medical Faculty Comenius University	2000 - today

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other	IV.b - Name of the institution	IV.c - Year
board certificate in the field of internal medicine	Institute for Further Postgradual Education for Medical Professionals (today Slovak Medical University Bratislava)	1996
board certificate in the field of clinical pharmacology	Slovak Postgradual Academy of Medicine (today Slovak Medical University Bratislava)	1999
board certificate in the field of diabetology and metabolic and nutritional disorders	Slovak Medical University Bratislava	2006
board certificate in the field of general practice	Slovak Medical University Bratislava	2012

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.1.a - Name of the profile course	V.1.b - Study programme	V.1.c - Degree	V.1.d - Field of study
pharmacology I, II	general medicine	MUDr.	general medicine
pharmacology I,II	dentistry	MDDr.	dentistry

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.b - Diploma (second degree)

V.4.2 - Number of defended theses

V.4.b - Diploma (second degree)

V.5 - Overview of other courses taught in the current academic year according to study programmes

V.5.a - Name of the course	V.5.b - Study programme	V.5.c - Degree	V.5.d - Field of study
Clinical pharmacology	general medicine	MUDr.	general medicine
Clinical pharmacology	pharmacy	Pharm.Dr.	pharmacy

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.a - Overall

161

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.a - Overall

196

VI.1.b - Over the last six years

150

VI.1.5 - Number of invited lectures at the international, national level

VI.1.b - Over the last six years

VI.2 - The most significant research/artistic/other outputs

Laššán Š., Tesař T., Tisoňová J., Laššánová M.: Pharmacological approaches to pulmonary fibrosis

following COVID-19. In: Frontiers in Pharmacology. - Roč. 14, č. Jun (2023), s. [1-13], art. no. 1143158. - ISSN (online) 1663-9812, (2022: = 5.6, JCR = Q1, SJR = Q1). (1 cit)

Petrova M, Lassanova M, Tisonova J, Liskova S. Ca²⁺-Dependent Cl^- Channels in Vascular Tone Regulation during Aging. Int J Mol Sci. 2024 May 7;25(10):5093. doi: 10.3390/ijms25105093. PMID: 38791133; PMCID: PMC11121552.

Hudec R, Božeková L, Tisoňová J. Consumption of three most widely used analgesics in six European countries. J Clin Pharm Ther. 2012 Feb;37(1):78-80. doi: 10.1111/j.1365-2710.2011.01256.x. Epub 2011 Apr 6. PMID: 21466569.

Hlavacova N, Wawruch M, Tisonova J, Jezova D. Neuroendocrine activation during combined mental and physical stress in women depends on trait anxiety and the phase of the menstrual cycle. Ann N Y Acad Sci. 2008 Dec;1148:520-5. doi: 10.1196/annals.1410.030. PMID: 19120151.

Tisonová J, Szalayová A, Kriska M, Gibala P, Foltán V. Factors influencing the spontaneous reporting of adverse drug reactions--the experience of the Slovak Republic. Pharmacoepidemiol Drug Saf. 2004 May;13(5):333-7. doi: 10.1002/pds.889. PMID: 15133786.

VI.3 - The most significant research/artistic/other outputs over the last six years

Laššán Š., Tesař T., Tisoňová J., Laššánová M.: Pharmacological approaches to pulmonary fibrosis

following COVID-19. In: Frontiers in Pharmacology. - Roč. 14, č. Jun (2023), s. [1-13], art. no. 1143158. - ISSN (online) 1663-9812, (2022: = 5.6, JCR = Q1, SJR = Q1). (1 cit)

Laššánová M., Líšková S., Tisoňová J. , Fundarková S., Laššán Š._ Biopharmaceuticals safety perception safety perception in Slovakia: considerations and real-life pharmacovigilance data

In: Bratislava medical journal. - Roč. 122, č. 7 (2021), s. 443-448. - ISSN (print) 0006-9248

(2020 IF (JCR) 1,28, JCR Q3, SJR Q3); (SJR 2021=1.564, JCR Q4, )

Tisoňová J., Renger, F., Czirfusz A.: Comparison of ordinary medical care centers/partnerships and practice clinic in Germany

In: Clinical Social Work and Health Intervention. - Roč. 10, č. 3 (2019), s. 41-49. - ISSN (print) 2222-386

WOS CC Web of Science Core Collection

Tisoňová J., Fábryová Ľ., Laššánová M.: Budúcnosť manažmentu dyslipidémií = The future of dyslipidemia management

In: Kardiológia pre prax. - Roč. 18, č. 2 (2020), s. 95-99. - ISSN (print) 1336-3433

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

Johnston, J. - Dorrian, D. - Linden, D. - Stanel, S.C. - Rivera-Ortega, P. - Chaudhuri, N.: Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease. In: Cells, vol. 12, no. 18, 2023, art. no. 2238 -- SCI; SCOPUS

Almenoff, J. - Tonning, J.M. - Gould, A.L. - Szarfman, A. - Hauben, M. - Ouellet-Hellstrom, R. - Ball, R. - LaCroix, K.: Drug Safety, vol. 28, no. 11, 2005, s. 981-1007 -- SCI ; SCOPUS

[o1] 2006 ~ Castberg, I. - Reimers, A. - Sandvik, P. - Aamo, T.O. - Spigset, O.: Nordic Journal of Psychiatry, vol. 60, no. 3, 2006, s. 227-233 -- SCI ; SCOPUS

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VEGA1/0024/21 Possibilities of pharmacoepidemiological analysis of adherence to preventive pharmacotherapy in elderly patients with peripheral vascular disease of the lower extremities. (principal investigator prof. MUDr. Martin Wawruch, Ph.D.)

VEGA1/0112/17 Adherence to pharmacotherapy - basic precondition to success in secondary prevention of cardiovascular diseases in elderly.

(principal investigator prof. MUDr. Martin Wawruch, Ph.D.)

VEGA1/0886/14 Suboptimal uase of drugs in secondary prevention of cardiovascular diseases in elderly.

(principal investigator prof. MUDr. Martin Wawruch, Ph.D.)

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position	VII.b - Name of the institution, board	VII.c - Duration
Organising of educational and scientific activity "Škola lipidológie a Nové trendy v prevencii aterosklerózy/School of lipidology and New trends in atheroscerosis prevention/. scientific secretary	Slovak association of atherosclerosis / Slovenská asociácia aterosklerózy	since 2019 - today, member of scientific board since 2015
organising scienfic and educational activities/Member of scientific board	Slovak society of clinical pharmacology	since 2007, scientific secretary (2011-2015)
External assessment of documents included in application for local drug registration - pharmacological-toxiciological and clinical part	State institute of drug control	Since 2004
External member of Commission for assessment and safety of drugs, chairwoman,	State institute of drug control	Since 2011, chairwoman since 2015

Name and surname:	doc. MUDr. Jana Tisoňová, PhD.
Document type:	Research/art/teacher profile of a person
The name of the university:	Comenius University Bratislava
The seat of the university:	Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

II. - Higher education and further qualification growth

II.1 - First degree of higher education

II.2 - Second degree of higher education

II.3 - Third degree of higher education

II.4 - Associate professor

II.5 - Professor

II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

IV. - Development of pedagogical, professional, language, digital and other skills

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes

V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year

V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year

V.4 - Overview of supervised final theses

V.4.1 - Number of currently supervised theses

V.4.2 - Number of defended theses

V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations

VI.1.1 - Number of the research/artistic/other outputs

VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases

VI.1.3 - Number of citations corresponding to the research/artistic/other outputs

VI.1.4 - Number of citations registered in the Web of Science or Scopus databases

VI.1.5 - Number of invited lectures at the international, national level

VI.2 - The most significant research/artistic/other outputs

VI.3 - The most significant research/artistic/other outputs over the last six years

VI.4 - The most significant citations corresponding to the research/artistic/other outputs

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts